Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia
The management of histologic transformation of CLL to aggressive lymphomas remains an unmet clinical need since the standard of care is not established. Treatment selection for patients with CLL without del(17p)/TP53 mutation should be individualized based patient’s age, performance status, comorbid conditions, as well as the agent’s toxicity profile. Oncologists and hematologists need to understand the unique challenges associated with the management of histologic transformation of CLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Chronic Lymphocytic Leukemia Patient Management Simulator
Recent advances in understanding the biology of chronic lymphocytic leukemia (CLL) have resulted in the development of novel therapies targeting key signaling pathways involved in the pathogenesis of this disease.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Enduring Activity
Credits
Debate - What is Optimal First-Line Therapy for Chronic Lymphocytic Leukemia: Chemoimmunotherapy or Small Molecule Inhibitor Therapy?
The treatment landscape of first-line therapy for chronic lymphocytic leukemia (CLL) has evolved significantly in recent years. Educating the clinicians about the recent clinical advances and the benefits/risks associated with the use of chemoimmunotherapy vs. targeted therapy can help them to make informed clinical decisions and develop an individualized treatment plan.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Approaches to Personalized Treatment for CLL: Expert Guidance on Sequencing Therapy and Novel Agents
The goal of this program is to improve the knowledge and competence of clinicians to implement best practices in the treatment of CLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation